Issue 114

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O Fridays.

Here's what's happening this week in the world of pharma digital

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases

Research Reports

All Research Reports
The Crossover Health Report
4.19.21
22 min. read
Analysis: Livongo founders’ HAAC SPAC
1.25.21
11 min. read
The UnitedHealth Group Report
12.30.20
30 min. read
The Virgin Pulse Report
9.25.20
14 min. read

Newsletters

All Newsletters
Prescription Digital Therapeutic Pipeline updates.
8.13.21
6 min. read
Virgin Pulse DTx bundle pricing. Red Bull’s stack
8.11.21
6 min. read
Seven quiet health tech funding deals. Puzzle answer
8.09.21
3 min. read
AI billing codes. Oura and the FDA. Trial updates.
8.06.21
8 min. read

Databases

All Databases
Digital health reimbursed in Germany via DiGA
9.17.21
< 1 min. read
What Public Digital Health Companies Pay Their Execs
9.03.21
< 1 min. read